Shares of Kraken Robotics bounced 4.6% to CA$7.78 on June 1, clawing back losses after a post-earnings selloff. The Newfoundland-based subsea technology firm reported Q1 2026 revenue of $21.7 million, up 35% from Q1 2025, with adjusted EBITDA of $3.0 million. The numbers reaffirmed management's ambitious full-year targets — but they also raised a basic math question for shareholders.
Product Sales Are Booming, but Q1 Only Covers a Fraction of the Year's Promise
Product revenue totaled $13.8 million, up 50% from $9.2 million a year earlier, driven by demand for the company's high-resolution underwater sonar and subsea battery products. That's impressive growth, but Kraken is guiding for full-year revenue of $165 million to $175 million — meaning Q1's $21.7 million represents barely 13% of the midpoint. Management says revenue is expected to be weighted toward the second half of 2026 , consistent with prior years' seasonal patterns. Investors must trust that a massive back-half ramp materializes.
A $615 Million Acquisition Could Transform — or Strain — the Company
Kraken entered into a definitive agreement to acquire Covelya Group, a provider of mission-critical underwater technology, for $615 million.
Year-to-date order intake for Covelya's products has reached $165 million.
The deal is expected to close near the end of Q2 2026 , at which point new combined guidance will be issued. For a company with ~$102 million in 2025 revenue, absorbing a deal six times that size introduces significant integration and financing risk.
Defence Demand Provides a Tailwind, but the Valuation Is Already Stretched
CEO Greg Reid pointed to growing traction with new defence customers and "strong" industry fundamentals driven by demand for autonomous underwater vehicles in military and energy sectors.
Yet at a recent P/S ratio of 24.5x, Kraken sits well above its electronics peers and the wider North American industry.
That's materially higher than both the industry average of 2.8x and the peer average of 18.1x.
The Bottom Line: At the midpoint, full-year guidance implies revenue growth of over 65% and EBITDA growth of 80%. Today's bounce looks like a relief trade, not a conviction buy. The real inflection point arrives when the Covelya deal closes and investors can finally judge whether Kraken's premium valuation matches the scale of its combined enterprise.